[Platelet activation and inflammation markers in patients with coronary heart disease and depression]

Terapevticheskii Arkhiv
|December 22, 2006
PubMed

Insights

Depression worsens platelet activity and inflammation in coronary heart disease (CHD) patients, increasing risks for blood clots. This study highlights how depression exacerbates platelet dysfunction and intravascular inflammation in CHD.

Area of Science:

  • Hematology and Cardiovascular Research
  • Investigates platelet morphology and function in cardiovascular disease.
  • Examines the interplay between inflammation markers and platelet activity.

Context:

  • Coronary heart disease (CHD) patients often experience comorbid depression.
  • Platelet activation and inflammation are key factors in thrombotic complications.
  • Understanding these relationships is crucial for managing CHD patients.

Purpose:

  • To investigate platelet morphological features and functional activity.
  • To assess the relationship between platelet parameters and inflammation markers in CHD patients with and without depression.
  • To determine the impact of depression on platelet behavior and inflammatory status in CHD.

Summary:

  • CHD patients exhibited enhanced spontaneous platelet aggregation, increased reticular platelets, and elevated mean platelet volume.
  • Depression significantly aggravated these platelet abnormalities and increased levels of inflammatory markers like IL-6, sVCAM, IL-2, and hsCRP.
  • Leukocytic-thrombocytic aggregates (LTA) and erythrocytic-thrombocytic aggregates (ETA) were observed, particularly in depressive CHD patients.

Impact:

  • Findings suggest depression stimulates platelet functional activity, acting as a risk factor for intravascular inflammation.
  • This heightened platelet activity and inflammation contribute to the development of thrombotic complications in CHD.
  • The study underscores the importance of addressing depression in CHD management to mitigate thrombotic risks.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Inflammation01:38

Inflammation

Overview
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...